These results seem to indicate that near-term savings can be achieved without triggering greater costs in the long run. This finding runs counter to an earlier finding that returning to treatment (over a 2-year window) was less likely among patients initially treated in an inpatient hospital setting than among those attending AA (Walsh et al. 1991). The tradeoff between near-term and later treatment costs clearly requires continued research attention.
